Back to Search
Start Over
Do the Side Effects of BRAF Inhibitors Mimic RASopathies?
- Source :
-
The Journal of investigative dermatology [J Invest Dermatol] 2017 Apr; Vol. 137 (4), pp. 805-809. - Publication Year :
- 2017
-
Abstract
- Recent advances in targeted anticancer therapies have substantially improved the prognosis of several cancers. Such targeted therapies are not, however, free of side effects, and these side effects are clearly distinct from those induced by classical cytotoxic chemotherapies. This is likely so because targeted therapies are designed to interfere with specific oncogenic signaling pathways rather than to inhibit cell proliferation in general. In fact, interference with specific signaling pathways may lead to effects that mimic those associated with genetic disorders due to alterations in the corresponding signaling pathways. Here, we compare the clinical effects of treatment with BRAF inhibitors with those of genetic RASopathies and find a striking overlap between the inhibitor-induced, iatrogenic dermatoses with the genodermatoses seen in patients with corresponding congenital RASopathies. We hope that such comparisons lead to a better understanding of the side effects of targeted therapies.<br /> (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Humans
Melanoma genetics
Melanoma pathology
Molecular Targeted Therapy methods
Prognosis
Protein Kinase Inhibitors administration & dosage
Proto-Oncogene Proteins B-raf genetics
Risk Assessment
Skin Neoplasms genetics
Skin Neoplasms pathology
Treatment Outcome
Melanoma drug therapy
Molecular Targeted Therapy adverse effects
Protein Kinase Inhibitors adverse effects
Proto-Oncogene Proteins B-raf drug effects
Skin Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1523-1747
- Volume :
- 137
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Journal of investigative dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 28340684
- Full Text :
- https://doi.org/10.1016/j.jid.2016.12.012